Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 35 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

Plain-language summary

Several existing systematic reviews have summarized the prevalence of dementia in mainland China, Hong Kong and Taiwan. However, many new studies have been reported in the past five years. Given the size of the Chinese population, prevalence estimates are of intense international interest. The aim of this study is to update prevalence data in these areas and examine variation across geographical areas and time periods using the new dataset. A literature search was conducted to identify prevalence studies published in Chinese and English between April 2012 and February 2017. Prevalence data from 21 new studies were extracted and added to the 76 studies identified from previous systematic reviews. Meta-regression was used to investigate variation across geographical areas (northern, central, southern and western China, Hong Kong and Taiwan) and time periods (pre-1990, 1990–1994, 1995–1999, 200–2004, 2005–2009, post-2010) adjusting for methodological factors and characteristics of study population. A subgroup analysis was conducted to investigate regional trends, focusing on Beijing and Shanghai, the two areas with the earliest studies before 1990. The results of meta-regression were used to estimate number of people with dementia by geographical areas. Compared to northern China, the prevalence of dementia was lower in the central (-1.0%; 95% CI: -2.2, 0.3), south (-1.7%; 95% CI: -3.1, -0.3), Hong Kong and Taiwan (-3.0%; 95%CI: -5.0, -1.0) but was higher in western area (2.8%; 95% CI: 0.1, 5.5) after adjusting for methodological factors. Although the pooled prevalence estimates increased from pre-1990 (1.9%) to post-2010 periods (6.4%), this trend was attenuated and became non-significant when taking into account methodological variation and geographical areas. Regional trends in Beijing and Shanghai showed considerable fluctuations. The estimated number of people with dementia was 9.5 million (5.3%; 95% CI: 4.3, 6.3) in all these areas. This update confirms geographical variation in dementia prevalence but the prevalence trend remain unclear in this region due to the substantial impact of heterogeneity in methodologies. Different societal development across areas may provide an opportunity to explore population-level risk factors and determinants across diverse life courses and advance strategies for global dementia prevention and risk reduction.

What this study adds

Evidence grade: Low

This updated review added 21 new studies to estimate dementia prevalence across regions of China, Hong Kong, and Taiwan. Reported effect size: 1.0%; 1.7%; 3.0%.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Wu, Y., Ali, G., Guerchet, M., Prina, M. A., Chan, K. Y., Prince, M. J., et al. (2017). [P4–555]: A SYSTEMATIC REVIEW AND META‐ANALYSIS OF THE PREVALENCE OF DEMENTIA IN MAINLAND CHINA, HONG KONG AND TAIWAN: 2017 UPDATE. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2017.07.718

Vancouver

Wu Y, Ali G, Guerchet M, Prina MA, Chan KY, Prince MJ, et al. [P4–555]: A SYSTEMATIC REVIEW AND META‐ANALYSIS OF THE PREVALENCE OF DEMENTIA IN MAINLAND CHINA, HONG KONG AND TAIWAN: 2017 UPDATE. Alzheimer s & Dementia. 2017. doi:10.1016/j.jalz.2017.07.718.

BibTeX

@article{wu2017-8cce8478,
  author  = {Wu, Yu‐Tzu and Ali, Gemma‐Claire and Guerchet, Maëlenn and Prina, Matthew A. and Chan, Kit Yee and Prince, Martin James and Brayne, Carol},
  title   = {{[P4–555]: A SYSTEMATIC REVIEW AND META‐ANALYSIS OF THE PREVALENCE OF DEMENTIA IN MAINLAND CHINA, HONG KONG AND TAIWAN: 2017 UPDATE}},
  journal = {Alzheimer s \& Dementia},
  year    = {2017},
  doi     = {10.1016/j.jalz.2017.07.718},
  url     = {https://doi.org/10.1016/j.jalz.2017.07.718}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This updated review added 21 new studies to estimate dementia prevalence across regions of China, Hong Kong, and Taiwan. It found prevalence was lower in central, southern, Hong Kong, and Taiwan areas but higher in western China, and pooled estimates rose from pre-1990 to post-2010.

Study details

How this study scored 35/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 2 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 4 of 4; Institution's track record 2 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. Total 35 of 100.35 of 100 points earned65 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 2 / 5 2017 — within 10 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.1 citations a year over 11 year(s) since 2017
Impact for its field and year 1 / 6 Cited 0.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 4 / 4 Last-listed author Carol Brayne: h-index 159 (OpenAlex, whole career)
Institution's track record 2 / 3 University of Cambridge: institution h-index 1,973 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 4 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Total 35 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Studies in the library that share something with this one. The line above each title says what.

Related studies in Risk factors from nearby years

Also tagged “prevalence”

1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Risk factors

See all studies in Risk factors →